Research / Schizophrenia / Study Back to all studies Active Not Recruiting NCT06192602
Effectiveness of Acceptance-based Adherence Therapy in Early Psychosis; Psychotic Disorders This study is active but not recruiting in China. It is testing Acceptance-based Adherence Therapy for Early Psychosis; Psychotic Disorders.
Schizophrenia Behavioral From 18 Years to 64 Years
Countries China
Status Active Not Recruiting
Registry ClinicalTrials.gov
Study type Behavioral
Study design Interventional i A study where researchers assign a treatment, tool, therapy, procedure, or program.
Age eligibility From 18 Years to 64 Years
Sponsor Chinese University of Hong Kong The study in practice Understand this study Who could participate? Listed age limits: 18 years to 64 years.
Compensation and expense reimbursement have not been verified for this summary.
What to know before participating A point to clarify This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Study clarity Things to check before joining Study start date Started: February 1, 2023
Recruitment status Active Not Recruiting
Enrollment listed in the registry 126
Sponsor Chinese University of Hong Kong
Sponsor type University
Study type Behavioral
Intervention type Psychotherapy / behavioral intervention
Study phase Not clearly listed
Locations China
Age range From 18 Years to 64 Years
Official registry ID NCT06192602
Official title Testing the Effectiveness of an Acceptance-based Adherence Therapy for People With Recent-onset Psychosis: A Randomized Controlled Trial Ask HopeStage to help me review this study This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT06192602. We help you review the study, but cannot decide medical eligibility.
Hong Kong, Hong Kong · China
A listed location does not confirm current availability.
FAQ Questions about this study Who is behind this study? The study sponsor is Chinese University of Hong Kong, a university.
Who can participate? Listed age limits: 18 years to 64 years.
Is this study still recruiting? The registry lists this study as active, but no longer recruiting.
Explore other studies Want to find a study that may fit you better? Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me